CARGO Therapeutics Inc. C... (CRGX)
CARGO Therapeutics Common Stock Statistics
Share Statistics
CARGO Therapeutics Common Stock has 46.05M shares outstanding. The number of shares has increased by 0.42% in one year.
| Shares Outstanding | 46.05M |
| Shares Change (YoY) | 0.42% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,504 |
| FTD / Avg. Volume | 0.67% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -3.87 and the forward PE ratio is -1.81. CARGO Therapeutics Common Stock's PEG ratio is -0.07.
| PE Ratio | -3.87 |
| Forward PE | -1.81 |
| PS Ratio | 0 |
| Forward PS | 0.5 |
| PB Ratio | 1.8 |
| P/FCF Ratio | -4.5 |
| PEG Ratio | -0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CARGO Therapeutics Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.79, with a Debt / Equity ratio of 0.08.
| Current Ratio | 13.79 |
| Quick Ratio | 13.79 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.18 |
| Debt / FCF | -0.2 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,003,005.99 |
| Employee Count | 167 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -79.1% in the last 52 weeks. The beta is 0.64, so CARGO Therapeutics Common Stock's price volatility has been higher than the market average.
| Beta | 0.64 |
| 52-Week Price Change | -79.1% |
| 50-Day Moving Average | 4.15 |
| 200-Day Moving Average | 13.2 |
| Relative Strength Index (RSI) | 47.14 |
| Average Volume (20 Days) | 821,224 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -187.37M |
| Net Income | -167.5M |
| EBITDA | -160.43M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.72 |
Balance Sheet
The company has 64.38M in cash and 29.43M in debt, giving a net cash position of 34.95M.
| Cash & Cash Equivalents | 64.38M |
| Total Debt | 29.43M |
| Net Cash | 34.95M |
| Retained Earnings | -312.65M |
| Total Assets | 414.05M |
| Working Capital | 319.99M |
Cash Flow
In the last 12 months, operating cash flow was -139.74M and capital expenditures -4.45M, giving a free cash flow of -144.19M.
| Operating Cash Flow | -139.74M |
| Capital Expenditures | -4.45M |
| Free Cash Flow | -144.19M |
| FCF Per Share | -3.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CRGX is $4, which is -8.7% lower than the current price. The consensus rating is "Hold".
| Price Target | $4 |
| Price Target Difference | -8.7% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 0.81 |
| Piotroski F-Score | 1 |